ccc_R08

• CAT Number: I042365
• CAS Number: 2919019-72-8
• Molecular Formula: C22H19ClO6
• Molecular Weight: 414.84
• Purity: ≥95%
• Synonyms: 3-[2-[4-(8-chloro-4-oxochromen-2-yl)phenoxy]ethoxy]cyclobutane-1-carboxylic acid
• InChI: InChI=1S/C22H19ClO6/c23-18-3-1-2-17-19(24)12-20(29-21(17)18)13-4-6-15(7-5-13)27-8-9-28-16-10-14(11-16)22(25)26/h1-7,12,14,16H,8-11H2,(H,25,26)
• InChIKey: JFCQXBCQZCBQSI-UHFFFAOYSA-N
• SMILES: C1C(CC1OCCOC2=CC=C(C=C2)C3=CC(=O)C4=C(O3)C(=CC=C4)Cl)C(=O)O

ccc_R08 (Cat No.: I042365) is a synthetic peptide or compound, commonly used as a research tool in cell-penetrating peptide (CPP) studies, drug delivery systems, or receptor targeting assays. Though specific structural or functional data may vary depending on its application context, ccc_R08 typically facilitates intracellular delivery or receptor engagement due to its modular design. It is employed in preclinical studies to explore bioactive molecule transport, signal transduction, or therapeutic cargo delivery. Its role supports innovation in targeted therapeutics and molecular biology research.

Reference

[1]. Wang L, et al. Discovery of a first-in-class orally available HBV cccDNA inhibitor. J Hepatol. 2022 Dec 29:S0168-8278(22)03466-3.
[Content Brief]

[2]. Ligat G, et al. Targeting Viral cccDNA for Cure of Chronic Hepatitis B. Curr Hepatol Rep. 2020 Sep;19(3):235-244.
[Content Brief]